Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CLS MedTurn was a leading provider of pharmaceutical reverse logistics and returns management services, formed by the merger of Carolina Logistics Services (CLS) and MedTurn. The company specialized in the processing and management of expired, damaged, or unsaleable pharmaceutical products for manufacturers, wholesalers, and healthcare providers. Its services ensured regulatory compliance with DEA and EPA standards while providing financial reconciliation for returned goods. In 2005, CLS MedTurn was acquired by Inmar, which integrated the business into its healthcare and supply chain service offerings. Today, its legacy operations continue as part of Inmar’s pharmaceutical returns and supply chain solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CLS MedTurn.